<HTML>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2017 [PPXK5GW761L0VL9H5F2Y]. www.edgarsuite.com -->
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:57.6pt;width:496.8pt><P align=center style='font:10pt Times New Roman;margin:0'><B>UNITED STATES</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Washington, D. C. 20549</B></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>FORM 8-K</B></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>CURRENT REPORT</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Date of Report</B> (<I>Date of earliest event reported</I>)</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>January 9, 2017 </B>(<I>November 6, 2017</I>)</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>CANNABIS SATIVA, INC.</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><I>(Exact name of registrant as specified in its charter)</I></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Nevada</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><I>(State or other jurisdiction of incorporation)</I></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>000-53571</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><I>(Commission File No.)</I></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>1646 W. Pioneer Blvd.</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Suite 120</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Mesquite, Nevada &nbsp;89027</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><I>(Address of principal executive offices and Zip Code)</I></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>(702) 346-3906</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><I>(Registrant&#8217;s telephone number, including area code)</I></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:37.25pt><P style='font:10pt Times New Roman;margin:0'>[ &nbsp;&nbsp;]</P>
</TD><TD valign=top style=width:459.55pt><P style='font:10pt Times New Roman;margin:0'>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>
</TD></TR>
<TR><TD valign=top style=width:37.25pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:459.55pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:37.25pt><P style='font:10pt Times New Roman;margin:0'>[ &nbsp;&nbsp;]</P>
</TD><TD valign=top style=width:459.55pt><P style='font:10pt Times New Roman;margin:0'>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>
</TD></TR>
<TR><TD valign=top style=width:37.25pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:459.55pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:26.55pt><TD valign=top style=width:37.25pt><P style='font:10pt Times New Roman;margin:0'>[ &nbsp;&nbsp;]</P>
</TD><TD valign=top style=width:459.55pt><P style='font:10pt Times New Roman;margin:0'>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>
</TD></TR>
<TR><TD valign=top style=width:37.25pt><P style='font:10pt Times New Roman;margin:0'>[ &nbsp;&nbsp;]</P>
</TD><TD valign=top style=width:459.55pt><P style='font:10pt Times New Roman;margin:0'>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>
</TD></TR>
</TABLE>
<HR style='page-break-after:always;border:0;height:3.75pt;background-color:#919191;margin:15pt 0'><P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:0pt'><B>ITEM 1.01</B></KBD><KBD style=margin-left:72pt></KBD><B>ENTRY INTO A MATERIAL DEFINITIVE AGREEEMENT </B>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Cannabis Sativa, Inc., a Nevada corporation (&#8220;CBDS&#8221;) and our subsidiary corporation, Prestocorp., a Delaware corporation (&#8220;PrestoDoctor&#8221;) entered into Sponsor and Advertisement Agreement with Trans-High Corporation, a New York corporation (&#8220;Trans-High&#8221;) and its consolidated subsidiary corporations on September 29, 2017, which agreement was amended and restated in its entirety on November 6, 2017 (the &#8220;Agreement&#8221;). &nbsp;In the Agreement, Trans-High &nbsp;granted to PrestoDoctor a two year right of first refusal to serve as the exclusive medical cannabis recommendation provider at each Cannabis Cup event sponsored by Trans-High &nbsp;during such term. &nbsp;The Agreement also calls for additional advertising benefits to PrestoDoctor and our other subsidiaries. &nbsp;As consideration for the promises contained in the Agreement Presto has agreed to certain revenue sharing provisions and has agreed to issue to Trans-High 1,000 shares of PrestoDoctor Series A Preferred Stock having an aggregate liquidation value of $1,000,000 and convertible following May 6, 2018 &nbsp;into 332,447 shares of CBDS common stock in the aggregate. </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:0pt'><B>ITEM 9.01</B></KBD><KBD style=margin-left:72pt></KBD><B>EXHIBITS.</B>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse;width:100%><TR><TD valign=bottom bgcolor=#BFBFBF style='border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><B>Exhibit</B></P>
</TD><TD valign=bottom bgcolor=#BFBFBF style='border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><B>Document Description</B></P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&#160; </P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&#160; </P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>10.1</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>Amended and Restated Sponsorship and Advertisement Agreement</P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<HR style='border:0;height:0;width:0;margin:15pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>-</FONT>2<FONT style=font-size:10pt>-</FONT></P>
<HR style='page-break-after:always;border:0;height:3.75pt;background-color:#919191;margin:15pt 0'><P align=center style='font:10pt Times New Roman;margin:0'><B><I>SIGNATURES</I></B></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD>Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD>Dated this 9<SUP>th</SUP> day of January 2018. &nbsp;&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse><TR><TD valign=top style=width:252pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=2 valign=top style=width:243.9pt><P style='font:10pt Times New Roman;margin:0'><B>CANNABIS SATIVA, INC.</B></P>
</TD></TR>
<TR><TD valign=top style=width:252pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=2 valign=top style=width:243.9pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:252pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=2 valign=top style=width:243.9pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:252pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:36pt><P style='font:10pt Times New Roman;margin:0'>BY:</P>
</TD><TD valign=top style=width:207.9pt><P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>__________________________________</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:252pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:36pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:207.9pt><P style='font:10pt Times New Roman;margin:0'>Mike Gravel</P>
</TD></TR>
<TR><TD valign=top style=width:252pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:36pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:207.9pt><P style='font:10pt Times New Roman;margin:0'>President</P>
</TD></TR>
</TABLE>
<HR style='border:0;height:0;width:0;margin:15pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>-</FONT>3<FONT style=font-size:10pt>-</FONT></P>
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "cbds_8k.htm", "description": "8-K", "secsgml_size_bytes": 10882}]
{"company-data": {"conformed-name": "Cannabis Sativa, Inc.", "cik": "0001360442", "assigned-sic": "7200", "irs-number": "201898270", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-53571", "film-number": "18519845"}, "business-address": {"street1": "1646 W. PIONEER BLVD.", "street2": "SUITE 120", "city": "MESQUITE", "state": "NV", "zip": "89027", "phone": "702-346-3906"}, "mail-address": {"street1": "1646 W. PIONEER BLVD.", "street2": "SUITE 120", "city": "MESQUITE", "state": "NV", "zip": "89027"}, "former-company": {"former-conformed-name": "Ultra Sun Corp", "date-changed": "20060424"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report
(
Date of earliest event reported
)
January 9, 2017
(
November 6, 2017
)
CANNABIS SATIVA, INC.
(Exact name of registrant as specified in its charter)
Nevada
(State or other jurisdiction of incorporation)
000-53571
(Commission File No.)
1646 W. Pioneer Blvd.
Suite 120
Mesquite, Nevada  89027
(Address of principal executive offices and Zip Code)
(702) 346-3906
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[   ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[   ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[   ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[   ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 1.01
ENTRY INTO A MATERIAL DEFINITIVE AGREEEMENT
Cannabis Sativa, Inc., a Nevada corporation ("CBDS") and our subsidiary corporation, Prestocorp., a Delaware corporation ("PrestoDoctor") entered into Sponsor and Advertisement Agreement with Trans-High Corporation, a New York corporation ("Trans-High") and its consolidated subsidiary corporations on September 29, 2017, which agreement was amended and restated in its entirety on November 6, 2017 (the "Agreement").  In the Agreement, Trans-High  granted to PrestoDoctor a two year right of first refusal to serve as the exclusive medical cannabis recommendation provider at each Cannabis Cup event sponsored by Trans-High  during such term.  The Agreement also calls for additional advertising benefits to PrestoDoctor and our other subsidiaries.  As consideration for the promises contained in the Agreement Presto has agreed to certain revenue sharing provisions and has agreed to issue to Trans-High 1,000 shares of PrestoDoctor Series A Preferred Stock having an aggregate liquidation value of $1,000,000 and convertible following May 6, 2018  into 332,447 shares of CBDS common stock in the aggregate.
ITEM 9.01
EXHIBITS.
Exhibit
Document Description
10.1
Amended and Restated Sponsorship and Advertisement Agreement
-
2
-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated this 9
th
day of January 2018.
CANNABIS SATIVA, INC.
BY:
__________________________________
Mike Gravel
President
-
3
-